Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Article | IMSEAR | ID: sea-225825

Résumé

Background: Organophosphate poisoning is a major cause of morbidity and mortality that poses public health problems in developing countries, including India. Clinical signs and symptoms of OP compound ingestion are often non-specific and clinical signs depend on the nature of the OP compound, the amount consumed the time lapse between exposure and admission to the hospital, and the severityMethods: In this prospective cohort study, we reported the clinical presentation of 50 patients with OP poisoning, and studied the correlation of serum K+, Na+, creatinine, and BUN with the prognostic significance. Result: Elevated serum creatinine along with hypokalemia was found to be strongly correlated with high mortality rates in patients with suicidal organophosphate poisoning. The correlation of clinical outcomes and low serum K+ was found to be statistically significant (p<0.001). Our study concludes that serum K+ (<3.6 mmol/l) and serum creatinine (>1.21 mg/dl) are poor prognostic indicators for patients presenting with suicidal OP poisoningConclusions: Our study concluded the association of hypokalemia and elevatedserum creatinine levels with poor clinical outcomes in OP poisoning patients, and recommends regular monitoring of these prognostic indicators in effective management of these patients.

2.
Indian J Med Sci ; 2010 June; 64(6) 281-284
Article Dans Anglais | IMSEAR | ID: sea-145541

Résumé

Plasma cell leukemia is a rare, aggressive form of multiple myeloma. A 35-year-old male presented with backache, generalized weakness, and facial puffiness. His complete blood count showed anemia and a high WBC count with atypical cells on peripheral smear. Bone marrow examination showed more than 90% of atypical plasma cells, confirming a diagnosis of plasma cell leukemia. Patient also had azotemia, hypercalcemia, and hyperuricemia. The patient was started on chemotherapy along with supportive care. Patient improved dramatically and he was discharged on regular follow-up.


Sujets)
Adulte , Antinéoplasiques/usage thérapeutique , Hémogramme , Accompagnement de la fin de la vie , Humains , Leucémie à plasmocytes/traitement médicamenteux , Leucémie à plasmocytes/épidémiologie , Mâle , Melphalan/usage thérapeutique , Prednisolone/usage thérapeutique , Thalidomide/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche